|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-0823-2023 - ETEST CLINICAL ERYTHROMYCIN EM 256 US S30, CATALOG 412333
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0824-2023 - ETEST CLINICAL FLUCONAZOLE FL 256 US S30, CATALOG 412333
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0825-2023 - ETEST CLINICAL IMIPENEM IP 32 US S30, CATALOG 412373
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0826-2023 - ETEST CLINICAL LEVOFLOXACIN LE 32 US S30, CATALOG 412392
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0827-2023 - ETEST CLINICAL MEROPENEM MP 32 US S30, CATALOG 412401
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0828-2023 - ETEST CLINICAL MINOCYCLINE MC 256 US S30, CATALOG 412407
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0829-2023 - ETEST CLINICAL RIFAMPICIN RI 32 US S30, CATALOG 412449
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0830-2023 - ETEST CLINICAL TOBRAMYCIN TM 256 US S30, CATALOG 412478
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0831-2023 - ETEST CLINICAL VANCOMYCIN VA 256 US S30, CATALOG 412486
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0832-2023 - BIOBALL K.RHIZOPHILA (30X20), CATALOG 412690
|
2
|
01/04/2023
|
Biomerieux Inc
|